Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13805332 | 1.00 | HPGD (0.35) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805240 | 0.98 | HPGD (0.35) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805160 | 0.97 | HPGD (0.36) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805348 | 0.97 | KDM4E (0.35) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805258 | 0.95 | HPGD (0.37) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805170 | 0.94 | HPGD (0.35) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805302 | 0.93 | HPGD (0.35) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805155 | 0.92 | HPGD (0.34) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805350 | 0.92 | KDM4E (0.33) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 | |
| SCHEMBL13805333 | 0.92 | HPGD (0.35) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8906518-B2 | Triazole derivative, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-12-09 | — | — | US | disclosed |
| US-8906518-B2 | Triazole derivative, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-12-09 | — | — | US | disclosed |
| US-20090160324-A1 | Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-25 | — | — | US | disclosed |
| US-20090160324-A1 | Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090160324-A1 | Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | GRIN3A, TEAD2, TBL3 | HPGD 1843/4885SMN1; SMN2 4658/4885ALDH1A1 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.